ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a targeted drug boost transplant success in older blood cancer patients?
Disease control Recruiting nowThis study tests whether adding venetoclax (a targeted pill) to standard chemotherapy before a donor stem cell transplant can improve outcomes for adults over 50 with acute myeloid leukemia or myelodysplastic syndrome. About 186 participants will be randomly assigned to receive e…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 26, 2026 11:39 UTC
-
Tailored transplant doses aim to improve blood cancer outcomes
Disease control Recruiting nowThis study tests a personalized approach to stem cell transplants for adults with blood cancers like leukemia and lymphoma. The chemotherapy and radiation doses are adjusted based on each patient's risk factors to try to improve outcomes. The goal is to see if this tailored plan …
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC